Report Detail

Request for Sample of this report

Pharma & Healthcare Global Nuclear Medicine/Radiopharmaceuticals Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM3218748
    • |
  • 01 April, 2019
    • |
  • Global
    • |
  • 122 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imaged—for example, positronemitting radiopharmaceuticals.

Scope of the Report:
Nuclear medicine is a medical specialty that allows modern diagnostics and treatments using radiopharmaceuticals original radiotracers. Radiopharmaceuticals are considered a special group of drugs and thus their preparation and use are regulated by a set of policies that have been adopted by individual member countries. In China, radioactive drug approval process is cumbersome, drug research and development cycle is too long and the high-end equipment of China mainly relies on imports, which restrict the development of nuclear medicine.
In application, nuclear medicine / radiopharmaceuticals is for treatment oncology, thyroid, cardiology and other dieses. The nuclear medicine / radiopharmaceuticals market is mainly driven by growing demand for treatment cardiology which accounts for nearly 42.19 % of total downstream consumption of Nuclear Medicine / Radiopharmaceuticals in China.
The worldwide market for Nuclear Medicine/Radiopharmaceuticals is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Nuclear Medicine/Radiopharmaceuticals in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
China Isotope & Radiation
Dongcheng
Jaco
Ciaeriar
Advanced Molecular-imaging Solution
Shanghai Atom Kexing

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Diagnostic
Therapeutic

Market Segment by Applications, can be divided into
Oncology
Thyroid
Cardiology

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nuclear Medicine/Radiopharmaceuticals product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nuclear Medicine/Radiopharmaceuticals, with price, sales, revenue and global market share of Nuclear Medicine/Radiopharmaceuticals in 2017 and 2018.
Chapter 3, the Nuclear Medicine/Radiopharmaceuticals competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nuclear Medicine/Radiopharmaceuticals breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Nuclear Medicine/Radiopharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Nuclear Medicine/Radiopharmaceuticals sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Nuclear Medicine/Radiopharmaceuticals Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Diagnostic
      • 1.2.2 Therapeutic
    • 1.3 Market Analysis by Applications
      • 1.3.1 Oncology
      • 1.3.2 Thyroid
      • 1.3.3 Cardiology
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 China Isotope & Radiation
      • 2.1.1 Business Overview
      • 2.1.2 Nuclear Medicine/Radiopharmaceuticals Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Dongcheng
      • 2.2.1 Business Overview
      • 2.2.2 Nuclear Medicine/Radiopharmaceuticals Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Jaco
      • 2.3.1 Business Overview
      • 2.3.2 Nuclear Medicine/Radiopharmaceuticals Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Jaco Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Ciaeriar
      • 2.4.1 Business Overview
      • 2.4.2 Nuclear Medicine/Radiopharmaceuticals Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Advanced Molecular-imaging Solution
      • 2.5.1 Business Overview
      • 2.5.2 Nuclear Medicine/Radiopharmaceuticals Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Shanghai Atom Kexing
      • 2.6.1 Business Overview
      • 2.6.2 Nuclear Medicine/Radiopharmaceuticals Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Nuclear Medicine/Radiopharmaceuticals Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Nuclear Medicine/Radiopharmaceuticals Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Nuclear Medicine/Radiopharmaceuticals Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Nuclear Medicine/Radiopharmaceuticals Market Analysis by Regions

    • 4.1 Global Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)
    • 4.3 Europe Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)
    • 4.5 South America Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

    5 North America Nuclear Medicine/Radiopharmaceuticals by Country

    • 5.1 North America Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Market Share by Country
      • 5.1.1 North America Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)
    • 5.3 Canada Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

    6 Europe Nuclear Medicine/Radiopharmaceuticals by Country

    • 6.1 Europe Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)
    • 6.3 UK Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)
    • 6.4 France Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)
    • 6.5 Russia Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)
    • 6.6 Italy Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals by Country

    • 7.1 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Country (2014-2019)
    • 7.2 China Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)
    • 7.3 Japan Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)
    • 7.4 Korea Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)
    • 7.5 India Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

    8 South America Nuclear Medicine/Radiopharmaceuticals by Country

    • 8.1 South America Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Market Share by Country
      • 8.1.1 South America Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals by Countries

    • 9.1 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate (2014-2019)

    10 Global Nuclear Medicine/Radiopharmaceuticals Market Segment by Type

    • 10.1 Global Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Type (2014-2019)
    • 10.2 Diagnostic Sales Growth and Price
      • 10.2.1 Global Diagnostic Sales Growth (2014-2019)
      • 10.2.2 Global Diagnostic Price (2014-2019)
    • 10.3 Therapeutic Sales Growth and Price
      • 10.3.1 Global Therapeutic Sales Growth (2014-2019)
      • 10.3.2 Global Therapeutic Price (2014-2019)

    11 Global Nuclear Medicine/Radiopharmaceuticals Market Segment by Application

    • 11.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2014-2019)
    • 11.2 Oncology Sales Growth (2014-2019)
    • 11.3 Thyroid Sales Growth (2014-2019)
    • 11.4 Cardiology Sales Growth (2014-2019)

    12 Nuclear Medicine/Radiopharmaceuticals Market Forecast (2019-2024)

    • 12.1 Global Nuclear Medicine/Radiopharmaceuticals Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Nuclear Medicine/Radiopharmaceuticals Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Nuclear Medicine/Radiopharmaceuticals Market Forecast (2019-2024)
      • 12.2.2 Europe Nuclear Medicine/Radiopharmaceuticals Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Market Forecast (2019-2024)
      • 12.2.4 South America Nuclear Medicine/Radiopharmaceuticals Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Market Forecast (2019-2024)
    • 12.3 Nuclear Medicine/Radiopharmaceuticals Market Forecast by Type (2019-2024)
      • 12.3.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Nuclear Medicine/Radiopharmaceuticals Market Share Forecast by Type (2019-2024)
    • 12.4 Nuclear Medicine/Radiopharmaceuticals Market Forecast by Application (2019-2024)
      • 12.4.1 Global Nuclear Medicine/Radiopharmaceuticals Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Nuclear Medicine/Radiopharmaceuticals Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Nuclear Medicine/Radiopharmaceuticals . Industry analysis & Market Report on Nuclear Medicine/Radiopharmaceuticals is a syndicated market report, published as Global Nuclear Medicine/Radiopharmaceuticals Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Nuclear Medicine/Radiopharmaceuticals market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,690.04
      		4,035.06
      		5,380.08
      		3,239.88
      		4,859.82
      		6,479.76
      		531,361.20
      		797,041.80
      		1,062,722.40
      		293,712.00
      		440,568.00
      		587,424.00
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo